Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
bioRxiv ; 2024 Apr 11.
Article in English | MEDLINE | ID: mdl-38645090

ABSTRACT

During mammalian reproduction, sperm are delivered to the female reproductive tract bathed in a complex medium known as seminal fluid, which plays key roles in signaling to the female reproductive tract and in nourishing sperm for their onwards journey. Along with minor contributions from the prostate and the epididymis, the majority of seminal fluid is produced by a somewhat understudied organ known as the seminal vesicle. Here, we report the first single-cell RNA-seq atlas of the mouse seminal vesicle, generated using tissues obtained from 23 mice of varying ages, exposed to a range of dietary challenges. We define the transcriptome of the secretory cells in this tissue, identifying a relatively homogeneous population of the epithelial cells which are responsible for producing the majority of seminal fluid. We also define the immune cell populations - including large populations of macrophages, dendritic cells, T cells, and NKT cells - which have the potential to play roles in producing various immune mediators present in seminal plasma. Together, our data provide a resource for understanding the composition of an understudied reproductive tissue with potential implications for paternal control of offspring development and metabolism.

2.
Anal Chem ; 96(9): 3886-3897, 2024 Mar 05.
Article in English | MEDLINE | ID: mdl-38377434

ABSTRACT

In vitro transcription (IVT) of mRNA is a versatile platform for a broad range of biotechnological applications. Its rapid, scalable, and cost-effective production makes it a compelling choice for the development of mRNA-based cancer therapies and vaccines against infectious diseases. The impurities generated during mRNA production can potentially impact the safety and efficacy of mRNA therapeutics, but their structural complexity has not been investigated in detail yet. This study pioneers a comprehensive profiling of IVT mRNA impurities, integrating current technologies with innovative analytical tools. We have developed highly reproducible, efficient, and stability-indicating ion-pair reversed-phase liquid chromatography and capillary gel electrophoresis methods to determine the purity of mRNA from different suppliers. Furthermore, we introduced the applicability of microcapillary electrophoresis for high-throughput (<1.5 min analysis time per sample) mRNA impurity profiling. Our findings revealed that impurities are mainly attributed to mRNA variants with different poly(A) tail lengths due to aborted additions or partial hydrolysis and the presence of double-stranded mRNA (dsRNA) byproducts, particularly the dsRNA 3'-loop back form. We also implemented mass photometry and native mass spectrometry for the characterization of mRNA and its related product impurities. Mass photometry enabled the determination of the number of nucleotides of different mRNAs with high accuracy as well as the detection of their size variants [i.e., aggregates and partial and/or total absence of the poly(A) tail], thus providing valuable information on mRNA identity and integrity. In addition, native mass spectrometry provided insights into mRNA intact mass, heterogeneity, and important sequence features such as poly(A) tail length and distribution. This study highlights the existing bottlenecks and opportunities for improvement in the analytical characterization of IVT mRNA, thus contributing to the refinement and streamlining of mRNA production, paving the way for continued advancements in biotechnological applications.


Subject(s)
Chromatography, Reverse-Phase , Nucleotides , RNA, Messenger/genetics , Mass Spectrometry/methods , Photometry , Chromatography, High Pressure Liquid/methods , Drug Contamination
3.
J Neuroeng Rehabil ; 21(1): 4, 2024 01 03.
Article in English | MEDLINE | ID: mdl-38172975

ABSTRACT

BACKGROUND: Recently we reported the design and evaluation of floating semi-implantable devices that receive power from and bidirectionally communicate with an external system using coupling by volume conduction. The approach, of which the semi-implantable devices are proof-of-concept prototypes, may overcome some limitations presented by existing neuroprostheses, especially those related to implant size and deployment, as the implants avoid bulky components and can be developed as threadlike devices. Here, it is reported the first-in-human acute demonstration of these devices for electromyography (EMG) sensing and electrical stimulation. METHODS: A proof-of-concept device, consisting of implantable thin-film electrodes and a nonimplantable miniature electronic circuit connected to them, was deployed in the upper or lower limb of six healthy participants. Two external electrodes were strapped around the limb and were connected to the external system which delivered high frequency current bursts. Within these bursts, 13 commands were modulated to communicate with the implant. RESULTS: Four devices were deployed in the biceps brachii and the gastrocnemius medialis muscles, and the external system was able to power and communicate with them. Limitations regarding insertion and communication speed are reported. Sensing and stimulation parameters were configured from the external system. In one participant, electrical stimulation and EMG acquisition assays were performed, demonstrating the feasibility of the approach to power and communicate with the floating device. CONCLUSIONS: This is the first-in-human demonstration of EMG sensors and electrical stimulators powered and operated by volume conduction. These proof-of-concept devices can be miniaturized using current microelectronic technologies, enabling fully implantable networked neuroprosthetics.


Subject(s)
Electric Stimulation Therapy , Muscle, Skeletal , Humans , Electromyography , Electrodes, Implanted , Muscle, Skeletal/physiology , Lower Extremity , Wireless Technology
4.
J Neuroeng Rehabil ; 20(1): 138, 2023 10 17.
Article in English | MEDLINE | ID: mdl-37848992

ABSTRACT

OBJECTIVE: We aim to determine a comprehensive set of requirements, perceptions, and expectations that people with spinal cord injury (SCI) and the clinicians in charge of their rehabilitation have regarding the use of wearable robots (WR) for gait rehabilitation. BACKGROUND: There are concerns due to the limited user acceptance of WR for gait rehabilitation. Developers need to emphasize understanding the needs and constraints of all stakeholders involved, including the real-life dynamics of rehabilitation centers. METHODS: 15 people with SCI, 9 without experience with WR and 6 with experience with these technologies, and 10 clinicians from 3 rehabilitation centers in Spain were interviewed. A directed content analysis approach was used. RESULTS: 78 codes grouped into 9 categories (physical results, usability, psychology-related codes, technical characteristics, activities, acquisition issues, context of use, development of the technologies and clinical rehabilitation context) were expressed by at least 20% of the users interviewed, of whom 16 were not found in the literature. The agreement percentage between each group and subgroup included in the study, calculated as the number of codes that more than 20% of both groups expressed, divided over the total amount of codes any of those two groups agreed on (≥ 20%), showed limited agreement between patients and clinicians (50.00%) and between both types of patients (55.77%). The limited accessibility and availability of lower limb exoskeletons for gait rehabilitation arose in most of the interviews. CONCLUSIONS: The limited agreement percentage between patients and clinicians indicates that including both types of users in the design process of these technologies is important, given that their requirements are complementary. Engaging users with prior technology experience is recommended, as they often exhibit strong internal consensus and articulate well-defined requirements. This study adds up the knowledge available in the literature and the new codes found in our data, which enlighten important aspects that ought to be addressed in the field to develop technologies that respond to users' needs, are usable and feasible to implement in their intended contexts. APPLICATION: The set of criteria summarized in our study will be useful to guide the design, development, and evaluation of WR for gait rehabilitation to meet user's needs and allow them to be implemented in their intended context of use.


Subject(s)
Exoskeleton Device , Spinal Cord Injuries , Wearable Electronic Devices , Humans , Spinal Cord Injuries/rehabilitation , Gait , Lower Extremity
5.
J Clin Med ; 11(17)2022 Aug 30.
Article in English | MEDLINE | ID: mdl-36079035

ABSTRACT

This study aimed: (1) to evaluate the hand motor fatigability in people with spinal cord injury (SCI) and compare it with measurements obtained form an able-bodied population; (2) to compare the hand motor fatigability in people with tetraplegia and in people with paraplegia; and (3) to analyse if motor fatigability is different in people with SCI with and without clinical significant perceived fatigability. MATERIALS AND METHODS: 96 participants with SCI (40 cervical and 56 thoracolumbar) and 63 able-bodied controls performed a simple hand isometric task to assess motor fatigability. The Fatigue Severity Scale was used for perceived fatigability evaluation. RESULTS: The main results of this study can be summarized as follows: (1) the waning in muscle force (motor fatigability) during a fatiguing task is similar in controls and participants with SCI; (2) the motor fatigability is influenced by the maximal muscle force (measured at the beginning of the task); and (3) the perceived fatigability and the motor fatigability are largely independent in the individuals with SCI. CONCLUSION: Our findings suggest that the capability to maintain a prolonged effort is preserved in SCI, and this capacity depends on the residual maximal muscle force in people with SCI.

6.
PLoS Genet ; 17(3): e1009416, 2021 03.
Article in English | MEDLINE | ID: mdl-33661909

ABSTRACT

Beyond the haploid genome, mammalian sperm carry a payload of epigenetic information with the potential to modulate offspring phenotypes. Recent studies show that the small RNA repertoire of sperm is remodeled during post-testicular maturation in the epididymis. Epididymal maturation has also been linked to changes in the sperm methylome, suggesting that the epididymis might play a broader role in shaping the sperm epigenome. Here, we characterize the genome-wide methylation landscape in seven germ cell populations from throughout the male reproductive tract. We find very few changes in the cytosine methylation landscape between testicular germ cell populations and cauda epididymal sperm, demonstrating that the sperm methylome is stable throughout post-testicular maturation. Although our sequencing data suggested that caput epididymal sperm exhibit a highly unusual methylome, follow-up studies revealed that this resulted from contamination of caput sperm by extracellular DNA. Extracellular DNA formed web-like structures that ensnared sperm, and was present only in sperm samples obtained from the caput epididymis and vas deferens of virgin males. Curiously, contaminating extracellular DNA was associated with citrullinated histone H3, potentially resulting from a PAD-driven genome decondensation process. Taken together, our data emphasize the stability of cytosine methylation in mammalian sperm, and identify a surprising, albeit transient, period during which sperm are associated with extracellular DNA.


Subject(s)
Cytosine/metabolism , DNA Methylation , Epigenome , Sperm Maturation/genetics , Spermatozoa/metabolism , Testis/metabolism , Animals , Cell Differentiation/genetics , Cell-Free Nucleic Acids , CpG Islands , Epididymis/cytology , Epididymis/metabolism , Female , Male , Mice , Spermatozoa/cytology
7.
Mol Metab ; 38: 100924, 2020 08.
Article in English | MEDLINE | ID: mdl-31974037

ABSTRACT

BACKGROUND: An organism's metabolic phenotype is primarily affected by its genotype, its lifestyle, and the nutritional composition of its food supply. In addition, it is now clear from studies in many different species that ancestral environments can also modulate metabolism in at least one to two generations of offspring. SCOPE OF REVIEW: We limit ourselves here to paternal effects in mammals, primarily focusing on studies performed in inbred rodent models. Although hundreds of studies link paternal diets and offspring metabolism, the mechanistic basis by which epigenetic information in sperm programs nutrient handling in the next generation remains mysterious. Our goal in this review is to provide a brief overview of paternal effect paradigms and the germline epigenome. We then pivot to exploring one key mystery in this literature: how do epigenetic changes in sperm, most of which are likely to act transiently in the early embryo, ultimately direct a long-lasting physiological response in offspring? MAJOR CONCLUSIONS: Several potential mechanisms exist by which transient epigenetic modifications, such as small RNAs or methylation states erased shortly after fertilization, could be transferred to more durable heritable information. A detailed mechanistic understanding of this process will provide deep insights into early development, and could be of great relevance for human health and disease.


Subject(s)
Germ-Line Mutation/genetics , Metabolism, Inborn Errors/genetics , Animals , DNA Methylation , Diet , Epigenesis, Genetic , Epigenomics , Germ Cells/metabolism , Humans , Male , Mammals/metabolism , Metabolic Diseases/etiology , Metabolic Diseases/genetics , Metabolism, Inborn Errors/etiology , Paternal Exposure/adverse effects , Phenotype , Spermatozoa/metabolism
8.
Nature ; 566(7744): E7, 2019 02.
Article in English | MEDLINE | ID: mdl-30723268

ABSTRACT

In this Letter, the 'Competing interests' statement should have stated: 'D.R.L. consults for and has equity in Vedanta Biosciences.' The original Letter has not been corrected.

9.
Immunity ; 49(1): 151-163.e5, 2018 07 17.
Article in English | MEDLINE | ID: mdl-29980437

ABSTRACT

The intestinal barrier is vulnerable to damage by microbiota-induced inflammation that is normally restrained through mechanisms promoting homeostasis. Such disruptions contribute to autoimmune and inflammatory diseases including inflammatory bowel disease. We identified a regulatory loop whereby, in the presence of the normal microbiota, intestinal antigen-presenting cells (APCs) expressing the chemokine receptor CX3CR1 reduced expansion of intestinal microbe-specific T helper 1 (Th1) cells and promoted generation of regulatory T cells responsive to food antigens and the microbiota itself. We identified that disruption of the microbiota resulted in CX3CR1+ APC-dependent inflammatory Th1 cell responses with increased pathology after pathogen infection. Colonization with microbes that can adhere to the epithelium was able to compensate for intestinal microbiota loss, indicating that although microbial interactions with the epithelium can be pathogenic, they can also activate homeostatic regulatory mechanisms. Our results identify a cellular mechanism by which the microbiota limits intestinal inflammation and promotes tissue homeostasis.


Subject(s)
CX3C Chemokine Receptor 1/metabolism , Gastrointestinal Microbiome/immunology , Intestinal Mucosa/immunology , Mononuclear Phagocyte System/immunology , T-Lymphocytes, Regulatory/immunology , Th1 Cells/immunology , Animals , Antigen Presentation , Bacterial Adhesion/immunology , Disease Models, Animal , Female , Homeostasis , Immune Tolerance , Immunity, Mucosal , Inflammation/immunology , Inflammatory Bowel Diseases/immunology , Interleukin-10/immunology , Interleukin-10/metabolism , Intestinal Mucosa/microbiology , Male , Mice , RAW 264.7 Cells
10.
Nature ; 554(7692): 373-377, 2018 02 15.
Article in English | MEDLINE | ID: mdl-29414937

ABSTRACT

Both microbial and host genetic factors contribute to the pathogenesis of autoimmune diseases. There is accumulating evidence that microbial species that potentiate chronic inflammation, as in inflammatory bowel disease, often also colonize healthy individuals. These microorganisms, including the Helicobacter species, can induce pathogenic T cells and are collectively referred to as pathobionts. However, how such T cells are constrained in healthy individuals is not yet understood. Here we report that host tolerance to a potentially pathogenic bacterium, Helicobacter hepaticus, is mediated by the induction of RORγt+FOXP3+ regulatory T (iTreg) cells that selectively restrain pro-inflammatory T helper 17 (TH17) cells and whose function is dependent on the transcription factor c-MAF. Whereas colonization of wild-type mice by H. hepaticus promoted differentiation of RORγt-expressing microorganism-specific iTreg cells in the large intestine, in disease-susceptible IL-10-deficient mice, there was instead expansion of colitogenic TH17 cells. Inactivation of c-MAF in the Treg cell compartment impaired differentiation and function, including IL-10 production, of bacteria-specific iTreg cells, and resulted in the accumulation of H. hepaticus-specific inflammatory TH17 cells and spontaneous colitis. By contrast, RORγt inactivation in Treg cells had only a minor effect on the bacteria-specific Treg and TH17 cell balance, and did not result in inflammation. Our results suggest that pathobiont-dependent inflammatory bowel disease is driven by microbiota-reactive T cells that have escaped this c-MAF-dependent mechanism of iTreg-TH17 homeostasis.


Subject(s)
Colitis/immunology , Colitis/microbiology , Helicobacter hepaticus/immunology , Immune Tolerance , Intestines/immunology , Intestines/microbiology , Proto-Oncogene Proteins c-maf/metabolism , T-Lymphocytes, Regulatory/immunology , Animals , Bioengineering , Colitis/pathology , Female , Forkhead Transcription Factors/metabolism , Helicobacter hepaticus/genetics , Helicobacter hepaticus/pathogenicity , Homeostasis , Host-Pathogen Interactions , Interleukin-10/biosynthesis , Interleukin-10/deficiency , Interleukin-10/immunology , Male , Mice , Nuclear Receptor Subfamily 1, Group F, Member 3/antagonists & inhibitors , Nuclear Receptor Subfamily 1, Group F, Member 3/metabolism , Proto-Oncogene Proteins c-maf/deficiency , T-Lymphocytes, Regulatory/cytology , T-Lymphocytes, Regulatory/metabolism , Th17 Cells/cytology , Th17 Cells/immunology
11.
Nat Immunol ; 16(7): 746-54, 2015 Jul.
Article in English | MEDLINE | ID: mdl-26030024

ABSTRACT

During development, progenitor cells with binary potential give rise to daughter cells that have distinct functions. Heritable epigenetic mechanisms then lock in gene-expression programs that define lineage identity. Regulation of the gene encoding the T cell-specific coreceptor CD4 in helper and cytotoxic T cells exemplifies this process, with enhancer- and silencer-regulated establishment of epigenetic memory for stable gene expression and repression, respectively. Using a genetic screen, we identified the DNA-methylation machinery as essential for maintaining silencing of Cd4 in the cytotoxic lineage. Furthermore, we found a requirement for the proximal enhancer in mediating the removal of DNA-methylation marks from Cd4, which allowed stable expression of Cd4 in helper T cells. Our findings suggest that stage-specific methylation and demethylation events in Cd4 regulate its heritable expression in response to the distinct signals that dictate lineage 'choice' during T cell development.


Subject(s)
DNA Methylation/immunology , Gene Expression/immunology , T-Lymphocytes, Cytotoxic/immunology , T-Lymphocytes, Helper-Inducer/immunology , Animals , CD4 Antigens/genetics , CD4 Antigens/immunology , CD4 Antigens/metabolism , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/metabolism , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/metabolism , Cell Differentiation/genetics , Cell Differentiation/immunology , Cell Lineage/genetics , Cell Lineage/immunology , Cells, Cultured , Chromatin/genetics , Chromatin/immunology , Chromatin/metabolism , DNA (Cytosine-5-)-Methyltransferase 1 , DNA (Cytosine-5-)-Methyltransferases/genetics , DNA (Cytosine-5-)-Methyltransferases/immunology , DNA (Cytosine-5-)-Methyltransferases/metabolism , Flow Cytometry , HEK293 Cells , Humans , Mice, Knockout , Mice, Transgenic , RNA Interference/immunology , T-Lymphocytes, Cytotoxic/metabolism , T-Lymphocytes, Helper-Inducer/metabolism , Transcription Factors/genetics , Transcription Factors/immunology , Transcription Factors/metabolism
12.
J Exp Med ; 211(8): 1571-83, 2014 Jul 28.
Article in English | MEDLINE | ID: mdl-25024136

ABSTRACT

Interleukin (IL)-22-producing group 3 innate lymphoid cells (ILC3) promote mucosal healing and maintain barrier integrity, but how microbial signals are integrated to regulate mucosal protection offered by these cells remains unclear. Here, we show that in vivo depletion of CX3CR1⁺ mononuclear phagocytes (MNPs) resulted in more severe colitis and death after infection with Citrobacter rodentium. This phenotype was rescued by exogenous IL-22, which was endogenously produced by ILC3 in close spatial proximity to CX3CR1⁺ MNPs that were dependent on MyD88 signaling. CX3CR1⁺MNPs from both mouse and human tissue produced more IL-23 and IL-1ß than conventional CD103(+) dendritic cells (cDCs) and were more efficient than cDCs in supporting IL-22 production in ILC3 in vitro and in vivo. Further, colonic ILC3 from patients with mild to moderate ulcerative colitis or Crohn's disease had increased IL-22 production. IBD-associated SNP gene set analysis revealed enrichment for genes selectively expressed in human intestinal MNPs. The product of one of these, TL1A, potently enhanced IL-23- and IL-1ß-induced production of IL-22 and GM-CSF by ILC3. Collectively, these results reveal a critical role for CX3CR1⁺ mononuclear phagocytes in integrating microbial signals to regulate colonic ILC3 function in IBD.


Subject(s)
Colitis/immunology , Colitis/pathology , Immunity, Innate , Interleukins/biosynthesis , Lymphocytes/metabolism , Phagocytes/metabolism , Receptors, Chemokine/metabolism , Animals , CX3C Chemokine Receptor 1 , Citrobacter rodentium/drug effects , Citrobacter rodentium/physiology , Colitis/microbiology , Colitis/prevention & control , Dendrites/drug effects , Dendrites/metabolism , Feces , Humans , Immunity, Innate/drug effects , Interleukin-1beta/pharmacology , Interleukin-23/metabolism , Intestinal Mucosa/drug effects , Intestinal Mucosa/pathology , Lymphocytes/drug effects , Lymphocytes/microbiology , Mice , Monocytes/drug effects , Monocytes/metabolism , Phagocytes/drug effects , Phagocytes/microbiology , Toll-Like Receptors/metabolism , Tumor Necrosis Factor Ligand Superfamily Member 15/metabolism , Interleukin-22
13.
Nature ; 494(7435): 116-20, 2013 Feb 07.
Article in English | MEDLINE | ID: mdl-23334413

ABSTRACT

The intestinal microbiota has a critical role in immune system and metabolic homeostasis, but it must be tolerated by the host to avoid inflammatory responses that can damage the epithelial barrier separating the host from the luminal contents. Breakdown of this regulation and the resulting inappropriate immune response to commensals are thought to lead to the development of inflammatory bowel diseases such as Crohn's disease and ulcerative colitis. We proposed that the intestinal immune system is instructed by the microbiota to limit responses to luminal antigens. Here we demonstrate in mice that, at steady state, the microbiota inhibits the transport of both commensal and pathogenic bacteria from the lumen to a key immune inductive site, the mesenteric lymph nodes (MLNs). However, in the absence of Myd88 or under conditions of antibiotic-induced dysbiosis, non-invasive bacteria were trafficked to the MLNs in a CCR7-dependent manner, and induced both T-cell responses and IgA production. Trafficking was carried out by CX(3)CR1(hi) mononuclear phagocytes, an intestinal-cell population previously reported to be non-migratory. These findings define a central role for commensals in regulating the migration to the MLNs of CX(3)CR1(hi) mononuclear phagocytes endowed with the ability to capture luminal bacteria, thereby compartmentalizing the intestinal immune response to avoid inflammation.


Subject(s)
Immunity, Mucosal/immunology , Lymph Nodes/immunology , Lymph Nodes/microbiology , Mesentery/immunology , Metagenome/physiology , Phagocytes/metabolism , Receptors, Chemokine/metabolism , Animals , Anti-Bacterial Agents/pharmacology , Antigens, Bacterial/immunology , CX3C Chemokine Receptor 1 , Cell Movement , Dendritic Cells/cytology , Dendritic Cells/immunology , Immunity, Mucosal/drug effects , Immunoglobulin A/immunology , Inflammation/immunology , Intestinal Mucosa/cytology , Intestinal Mucosa/immunology , Intestinal Mucosa/microbiology , Metagenome/immunology , Mice , Mice, Inbred C57BL , Myeloid Differentiation Factor 88/deficiency , Myeloid Differentiation Factor 88/metabolism , Phagocytes/cytology , Phagocytes/immunology , Phagocytes/microbiology , Phagocytosis , Receptors, CCR7/deficiency , Receptors, CCR7/genetics , Receptors, CCR7/metabolism , Salmonella/cytology , Salmonella/drug effects , Salmonella/immunology , T-Lymphocytes/immunology
14.
Cell ; 151(2): 289-303, 2012 Oct 12.
Article in English | MEDLINE | ID: mdl-23021777

ABSTRACT

Th17 cells have critical roles in mucosal defense and are major contributors to inflammatory disease. Their differentiation requires the nuclear hormone receptor RORγt working with multiple other essential transcription factors (TFs). We have used an iterative systems approach, combining genome-wide TF occupancy, expression profiling of TF mutants, and expression time series to delineate the Th17 global transcriptional regulatory network. We find that cooperatively bound BATF and IRF4 contribute to initial chromatin accessibility and, with STAT3, initiate a transcriptional program that is then globally tuned by the lineage-specifying TF RORγt, which plays a focal deterministic role at key loci. Integration of multiple data sets allowed inference of an accurate predictive model that we computationally and experimentally validated, identifying multiple new Th17 regulators, including Fosl2, a key determinant of cellular plasticity. This interconnected network can be used to investigate new therapeutic approaches to manipulate Th17 functions in the setting of inflammatory disease.


Subject(s)
Gene Regulatory Networks , Th17 Cells/cytology , Th17 Cells/metabolism , Animals , Basic-Leucine Zipper Transcription Factors/metabolism , Cell Differentiation , Encephalomyelitis, Autoimmune, Experimental/immunology , Fos-Related Antigen-2/immunology , Fos-Related Antigen-2/metabolism , Genome-Wide Association Study , Humans , Interferon Regulatory Factors/metabolism , Mice , Mice, Knockout , Molecular Sequence Data , Nuclear Receptor Subfamily 1, Group F, Member 3/metabolism , Th17 Cells/immunology
15.
Rev. cient. (Maracaibo) ; 17(4): 380-385, jul.-ago. 2007. tab
Article in Spanish | LILACS | ID: lil-548504

ABSTRACT

El objetivo del presente trabajo consistió en evaluar el efecto de la diferencia de grasa dorsal, antes del parto y al momento del destete. Para este trabajo se emplearon 656 hembras reproductoras de las razas: Duroc, Landrace, Yorkshire, F1 (Y x L) y F2 (DL x YL), en las que se realizaron dos mediciones del espesor de grasa dorsal: una semana antes del parto y al momento del destete, para evaluar el efecto de raza (R), número de parto (NP), consumo de alimento de la hembra durante la lactancia (CAL), tamaño de la camada al destete (TCD), ganancia de peso de la camada durante la lactancia (GPCL) y días de lactancia (DL) y sobre la diferencia entre la grasa dorsal de entrada y salida de la maternidad. Se encontró que la raza de la hembra no afecta la diferencia de grasa dorsal (P>0,05); pero el número de parto influye aumentando dicha variable, especialmente en las hembras de primero y segundo parto (P<0,05). Para grasa dorsal de salida, las hembras primerizas presentaron una menor cantidad de grasa (P<0,01), esta variable esta relacionada con el consumo de alimento (P<0,05) y los lechones destetados (P<0,05). Finalmente se encontró que a mayor tamaño de camada al destete (R=0,982) y a mayor ganancia de peso de los lechones (R=0,937), existe una mayor pérdida de grasa en la hembra. Se recomienda que para evitar una pérdida excesiva de reservas corporales, que repercuta en los siguientes ciclos reproductivos se establezca la medición de grasa dorsal al inicio y al final de la lactancia como parámetro de medición. Con las hembras primerizas se sugiere, optimizar la edad y peso a la primera monta.


The aim of this project was to evaluate the difference of backfat thickness before the birth and at the weaning, of it, 656 reproductive sows was used of the following breeds: Duroc, Landrace, Yorfkshire, F1 (Y x L) and F2 (D x YL), in which two measurements of the back fat were taken: one week before the birth and the other one at the weaning to evaluate: breed’s effect (R), farrow number (NP), the sow’s consumption of food during the lactation (CAL), size of the litter at the weaning (TCD), gain weight of the litter during the lactation period (GPCL) and lactation days (DL), all this related to the difference between back fat at the moment to enter into the farrowing room and at the moment to come out of the farrowing room. It was showed that the sow’s breed doesn’t affect the fat difference (P>0.05), but the farrow number has an influence increasing such variable, particularly first and second farrow animals (P<0.05). For the exit backfat the gilts showed a low quantity of fat (P<0.01) and such variable is related to the food consumption (P<0.05) and the weaned piglets (P<0.01). Finally it was determined that a greater litter size at weaning (R=0.982) and also a greater gain weight of the piglets (R=0.937) there is a grater loss of backfat in the sow. To prevent an excessive loss of the body reserves that can have an effect in the following reproductive cycles, it is recommended to establish a measurement of back fat at the beginning and at the end of the lactation period as parameter of measurement. With gilts it is recommended to optimize the age and weight at the first mating.


Subject(s)
Animals , Female , Infant , Animal Feed/analysis , Dietary Fats , Swine/metabolism , Weaning , Animal Nutrition Sciences , Veterinary Medicine
SELECTION OF CITATIONS
SEARCH DETAIL
...